Attovia Therapeutics develops advanced biotherapeutics targeting immune-mediated diseases through its innovative Attobody™ platform. By generating biparatopic binders, Attovia aims to broaden treatment options with enhanced efficacy and safety, advancing multiple programs designed to address various disease indications.
No jobs found. Subscribe below to get notified when we find something for you.
Searching